HBV DNA is a substrate for the cGAS/STING pathway but is not sensed in infected hepatocytes
preprint
OA: closed
CC-BY-4.0
Abstract
HBV chronic infection is a critical risk factor for hepatocellular carcinoma. Although debated, the absence of innate immune response to HBV infection in hepatocytes is becoming the current view. However the underlying reasons are poorly understood. This study aims to define potential viral pathogen-associated molecular patterns (PAMPs) and the pattern recognition receptors (PRRs), and to elucidate whether HBV counteracts the innate pathways. The innate immune response to HBV infection was monitored by interferon-stimulated gene 54 (ISG54) mRNA, a direct downstream transcriptional target of Interferon Regulatory Factor 3 (IRF3), or IRF3 phosphorylation. The immunostimulatory potential of naked HBV DNAs or RNAs and the respective PRRs were determined upon viral nucleic acid transfection in immunocompetent cells including knockout cells lacking key molecules of innate pathways. The expression and functionality of DNA and RNA sensing pathways in primary human hepatocytes (PHH) were assessed. The inhibition of the DNA-sensing pathway by HBV was tested using IRF3 nuclear translocation assay. Our study revealed that HBV infection does not induce an innate response in infected hepatocytes, even in absence of HBV X protein. HBV relaxed-circular DNA (rcDNA) and DNA replication intermediates, but not HBV RNAs, are immunostimulatory and sensed by Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS) and Stimulator of Interferon Genes (STING). Although PHH express DNA sensors to reduced levels compared to myeloid cells, they can respond to naked HBV rcDNA. However, we show that the absence of innate response to HBV infection in hepatocytes is not due to an active inhibition of the DNA sensing pathway by the virus. HBV passively evades the innate immune response in infected hepatocytes by (i) producing non-immunostimulatory RNAs, (ii) avoiding sensing of its DNAs by cGAS/STING without active inhibition of the pathway, possibly through shielding of the viral DNAs by the capsid. Author summary Innate immune responses are the first line of defense against viral infections. They lead to the production of antiviral factors after recognition of specific viral features by the infected cells. Here we show that HBV, a major cause of liver cirrhosis and cancer, avoids recognition by infected hepatocytes through different means. First, HBV RNAs, contrarily to other viral RNAs, are not immunostimulatory. Second, we show that naked HBV DNAs are recognized by cGAS/STING and induce an innate immune response. Furthermore, we demonstrate that this pathway is active in hepatocytes and is not inhibited by the virus. Instead, we propose that HBV DNAs are not accessible to cGAS/STING in the context of an infection. This might be due to shielding of the viral DNA by the viral capsid.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (52)
- doi:10.1016/j.chom.2017.07.012 via crossref
- doi:10.1038/nrmicro.2016.45 via crossref
- doi:10.4049/jimmunol.1300512 via crossref
- doi:10.1016/j.immuni.2014.12.016 via crossref
- doi:10.1073/pnas.1412631111 via crossref
- doi:10.1016/j.jhep.2015.07.014 via crossref
- doi:10.1093/infdis/jiu599 via crossref
- doi:10.1002/hep.30815 via crossref
- doi:10.1016/j.jhep.2015.11.039 via crossref
- doi:10.1073/pnas.0401771101 via crossref
- doi:10.1128/jvi.01844-08 via crossref
- doi:10.1053/j.gastro.2009.06.054 via crossref
- doi:10.1111/febs.13563 via crossref
- doi:10.3390/v9010005 via crossref
- doi:10.1016/j.jhep.2005.02.033 via crossref
- doi:10.4049/jimmunol.0903874 via crossref
- doi:10.1038/srep24865 via crossref
- doi:10.1002/hep.22751 via crossref
- doi:10.1099/vir.0.020552-0 via crossref
- doi:10.1371/journal.ppat.1000986 via crossref
- doi:10.3892/ijmm.2012.1131 via crossref
- doi:10.1128/jvi.01825-10 via crossref
- doi:10.1038/cmi.2017.1 via crossref
- doi:10.1053/j.gastro.2011.02.057 via crossref
- doi:10.1128/jvi.02760-14 via crossref
- doi:10.1053/j.gastro.2018.01.034 via crossref
- doi:10.1053/j.gastro.2018.01.044 via crossref
- doi:10.1128/jvi.76.11.5532-5539.2002 via crossref
- doi:10.1006/bbrc.2001.4913 via crossref
- doi:10.1016/j.jhep.2015.06.023 via crossref
- doi:10.1128/jvi.01300-07 via crossref
- doi:10.1371/journal.ppat.1003989 via crossref
- doi:10.1128/aac.41.8.1715 via crossref
- doi:10.1016/j.virusres.2007.12.024 via crossref
- doi:10.1371/journal.ppat.1005546 via crossref
- doi:10.1016/j.cell.2015.04.050 via crossref
- doi:10.1093/nar/gkw551 via crossref
- doi:10.1073/pnas.1515152113 via crossref
- doi:10.3748/wjg.v13.i1.48 via crossref
- doi:10.1128/jvi.57.1.229-236.1986 via crossref
- doi:10.1073/pnas.1808319115 via crossref
- doi:10.1002/hep.30897 via crossref
- doi:10.1128/jvi.01263-15 via crossref
- doi:10.1371/journal.ppat.1004343 via crossref
- doi:10.1053/j.gastro.2013.12.024 via crossref
- doi:10.1128/aac.41.8.1715 via crossref
- doi:10.1016/j.jhep.2011.02.015 via crossref
- doi:10.15252/embj.201488726 via crossref
- doi:10.3748/wjg.v11.i14.2080 via crossref
- doi:10.1159/000360948 via crossref
- doi:10.2144/00286st04 via crossref
- doi:10.1128/cdli.11.2.406-410.2004 via crossref
Source provenance
- crossref
- last seen: 2026-05-28T01:00:14.818541+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0